Biocon: Successfully raises ₹4,150 crore via QIP. SBI MF and ICICI Prudential MF each acquire over 5% stake; Mirae Asset MF also crosses the 5% threshold.

Deepak Fertilisers: Maharashtra tax authority reduces penalty to ₹96 crore from ₹478 crore.

Cipla: US arm pauses production of Lanreotide; re-supply expected in H1 FY27. Drug is used for treating acromegaly and related conditions.

Kernex Microsystems: Bags a ₹2,466 crore order from Chittaranjan Locomotive Works for KAVACH locomotive equipment.

Shilpa Medicare: Subsidiary Koanna Healthcare allots 2.8 crore shares worth CAD 2,000 to a Canadian investor; ceases to be a wholly owned subsidiary.

Zydus Lifesciences: Receives USFDA approval for Eltrombopag tablets. Arm completes acquisition of two Agenus biologics units, acquires 5.9% stake in Agenus, and secures India & Sri Lanka rights for Botensilimab and Batstilimab.

Infosys: Completes merger of Romania-based step-down subsidiaries In-tech Engineering Services and ProIT SRLRO on January 14.

Indian Hotels: To acquire ~51% stake in Brij Hospitality for ₹225 crore.

NTPC Green: Forms a 50:50 JV with GAIL for renewable projects. Declares commercial operations for part capacities of its Gujarat (150 MW) and Rajasthan (300 MW) solar projects.

Zen Technologies: Secures ₹404 crore defence orders, including ₹332 crore for anti-drone systems.

JSW Energy: Arm signs agreement with Toshiba JSW to procure two 800 MW steam turbine generators for Salboni thermal project.

HG Infra Engineering: Signs pact to divest 100% stake in HG Khammam Devarapalle to Neo Infra Income Opportunities Fund.

HBL Engineering: Did not receive new orders in the recent KAVACH locomotive tender; existing KAVACH orders stand at ₹900 crore, with expected FY27 sales of ₹1,000 crore.

JSW Infrastructure: Receives no-objection for change in shareholding of JSW Rail, JSW Minerals and JSW South in favour of JSWPLPL.

PDS: Hong Kong subsidiary acquires the remaining 15% stake in JCraft.

JTEKT India: Receives a ₹43 crore order from the Haryana tax authority.

NephroPlus Health: Board approves a USD 6 million corporate guarantee for its Philippines subsidiary to support working capital.

Fedbank Financial Services: Confirms no deviation in IPO fund utilisation of ₹1,092 crore; no funds utilised during Q3 FY26.

Aadhar Housing Finance: RBI approves acquisition of up to 28.20 crore shares by BCP Asia II Holdco VII Pte. Ltd. under SEBI takeover norms.

Atul Auto: Approves acquisition of L5 electric three-wheeler business from Atul Greentech via slump sale.

RailTel Corporation: Receives Letter of Acceptance worth ₹88 crore from Central Railway.

CEAT: Invests ₹32 crore for 26% stake each in Clean Max Como and Clean Max Emerald to develop ~59 MW wind-solar projects across Gujarat and Tamil Nadu.

Transrail Lighting: Bags ₹527 crore orders across MENA, Africa and India; FY26 cumulative order inflow reaches ₹5,637 crore.

Himadri Speciality Chemical: Invests AUD 37.03 lakh in Sicona Battery Technologies; holds 1.41 crore compulsorily convertible notes.

Disclaimer:

This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.

Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.